切换至 "中华医学电子期刊资源库"

中华心脏与心律电子杂志 ›› 2022, Vol. 10 ›› Issue (03) : 171 -174. doi: 10.3877/cma.j.issn.2095-6568.2022.03.009

所属专题: 总编推荐

综述

冠状动脉钙化特征在心血管风险评估中的价值
马亚南1, 吕滨1,()   
  1. 1. 100037 北京,中国医学科学院?北京协和医学院?国家心血管病中心?阜外医院放射影像科
  • 收稿日期:2022-05-04 出版日期:2022-09-25
  • 通信作者: 吕滨
  • 基金资助:
    国家重点研发计划(2016YFC1300400)

Value of coronary artery calcium characteristics in cardiovascular risk assessment

Yanan Ma1, Bin Lyu1,()   

  1. 1. Department of Radiology, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China
  • Received:2022-05-04 Published:2022-09-25
  • Corresponding author: Bin Lyu
引用本文:

马亚南, 吕滨. 冠状动脉钙化特征在心血管风险评估中的价值[J]. 中华心脏与心律电子杂志, 2022, 10(03): 171-174.

Yanan Ma, Bin Lyu. Value of coronary artery calcium characteristics in cardiovascular risk assessment[J]. Chinese Journal of Heart and Heart Rhythm(Electronic Edition), 2022, 10(03): 171-174.

冠状动脉钙化(CAC)作为亚临床粥样硬化的标记物,可以反映冠状动脉粥样硬化的总体负荷,是对患者进行心血管风险分层和诊疗的重要工具。临床上评估和量化CAC最常用的是Agatston积分,此外,钙化的分布、密度、体积、形态等特征在风险评估及诊疗方面均具有指导意义。本文将从CAC多个特征的临床意义进行总结,为深刻理解CAC在心血管风险评估中的作用提供思路。

[1]
Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography[J]. J Am Coll Cardiol, 1990, 15(4):827-832.
[2]
Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction[J]. JAMA, 2010, 303(16):1610-1616.
[3]
AlJaroudi W, Mansour MJ, Chedid M, et al. Incremental value of stress echocardiography and computed tomography coronary calcium scoring for the diagnosis of coronary artery disease[J]. Int J Cardiovasc Imaging, 2019, 35(6):1133-1139.
[4]
Blaha MJ, Cainzos-Achirica M, Greenland P, et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the multi-ethnic study of atherosclerosis (MESA)[J]. Circulation, 2016, 133(9):849-858.
[5]
Dzaye O, Dardari ZA, Cainzos-Achirica M, et al. Warranty period of a calcium score of zero: comprehensive analysis from MESA[J]. JACC Cardiovasc Imaging, 2021, 14(5):990-1002.
[6]
Winther S, Nissen L, Westra J, et al. Pre-test probability prediction in patients with a low to intermediate probability of coronary artery disease: a prospective study with a fractional flow reserve endpoint[J]. Eur Heart J Cardiovasc Imaging, 2019, 20(11):1208-1218.
[7]
陈璐, 王国宏, 郭彩霞. 冠状动脉CT血管成像对冠心病预后预测价值及治疗策略的指导意义[J]. 心血管病学进展, 2022, 43(2):108-112.
[8]
Rifai MA, Blaha MJ, Patel J, et al. Coronary artery calcification, statin use and long-term risk of atherosclerotic cardiovascular disease events (from the multi-ethnic study of atherosclerosis)[J]. Am J Cardiol, 2020, 125(6):835-839.
[9]
Budoff MJ, Young R, Burke G, et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA)[J]. Eur Heart J, 2018, 39(25):2401-2408.
[10]
Kim J, Budoff MJ, Nasir K, et al. Thoracic aortic calcium, cardiovascular disease events, and all-cause mortality in asymptomatic individuals with zero coronary calcium: The Multi-Ethnic Study of Atherosclerosis (MESA)[J]. Atherosclerosis, 2017, 257:1-8.
[11]
Lee JH, Rizvi A, Hartaigh , et al. The predictive value of coronary artery calcium scoring for major adverse cardiac events according to renal function (from the Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes: An International Multicenter [CONFIRM] Registry)[J]. Am J Cardiol, 2019, 123(9):1435-1442.
[12]
Peng AW, Mirbolouk M, Orimoloye OA, et al. Long-term all-cause and cause-specific mortality in asymptomatic patients with CAC ≥1,000: results from the CAC Consortium[J]. JACC Cardiovasc Imaging, 2020, 13(1 Pt 1):83-93.
[13]
Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines[J]. Circulation, 2019, 139(25):e1082-e1143.
[14]
Arnett D K, Blumenthal R S, Albert M A, et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines[J]. Circulation, 2019, 140(11):e596-e646.
[15]
Cainzos-Achirica M, Miedema MD, McEvoy JW, et al. Coronary artery calcium for personalized allocation of aspirin in primary prevention of cardiovascular disease in 2019: the MESA study (multi-ethnic study of atherosclerosis)[J]. Circulation, 2020, 141(19):1541-1553.
[16]
Wang M, Hou ZH, Xu H, et al. Association of estimated long-term exposure to air pollution and traffic proximity with a marker for coronary atherosclerosis in a nationwide study in China[J]. JAMA Netw Open, 2019, 2(6):e196553.
[17]
Blaha MJ, Budoff MJ, Tota-Maharaj R, et al. Improving the CAC score by addition of regional measures of calcium distribution: multi-ethnic study of atherosclerosis[J]. JACC Cardiovasc Imaging, 2016, 9(12):1407-1416.
[18]
Lahti SJ, Feldman DI, Dardari Z, et al. The association between left main coronary artery calcium and cardiovascular-specific and total mortality: the Coronary Artery Calcium Consortium[J]. Atherosclerosis, 2019, 286:172-178.
[19]
Foldyna B, Eslami P, Scholtz JE, et al. Density and morphology of coronary artery calcium for the prediction of cardiovascular events: insights from the Framingham Heart Study[J]. Eur Radiol, 2019, 29(11):6140-6148.
[20]
Hecht HS, Blaha MJ, Kazerooni EA, et al. CAC-DRS: coronary artery calcium data and reporting system. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT)[J]. J Cardiovasc Comput Tomogr, 2018, 12(3):185-191.
[21]
Jin HY, Weir-McCall JR, Leipsic JA, et al. The relationship between coronary calcification and the natural history of coronary artery disease[J]. JACC Cardiovasc Imaging, 2021, 14(1):233-242.
[22]
Criqui MH, Denenberg JO, Ix JH, et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events[J]. JAMA, 2014, 311(3):271-278.
[23]
Lo-Kioeng-Shioe MS, Vavere AL, Arbab-Zadeh A, et al. Coronary calcium characteristics as predictors of major adverse cardiac events in symptomatic patients: insights from the CORE 320 multinational study[J]. J Am Heart Assoc, 2019, 8(6):e007201.
[24]
Bellasi A, Ferramosca E, Ratti C, et al. The density of calcified plaques and the volume of calcium predict mortality in hemodialysis patients[J]. Atherosclerosis, 2016, 250:166-171.
[25]
van Rosendael AR, Narula J, Lin FY, et al. Association of high-density calcified 1k plaque with risk of acute coronary syndrome[J]. JAMA Cardiol, 2020, 5(3):282-290.
[26]
刘晔弘, 张奇. 冠状动脉钙化的临床研究进展[J]. 国际心血管病杂志, 2021, 48(6):337-340.
[27]
Cerci R, Vavere AL, Miller JM, et al. Patterns of coronary arterial lesion calcification by a novel, cross-sectional CT angiographic assessment[J]. Int J Cardiovasc Imaging, 2013, 29(7):1619-1627.
[28]
Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J]. Catheter Cardiovasc Interv, 2012, 79(3):453-495.
[29]
尹卫华, 李响楠, 田涛, 等. 钙化斑块特征预测经皮冠状动脉介入治疗术中旋磨[J]. 中国医学影像技术, 2020, 36(2):165-170.
[30]
Sekimoto T, Akutsu Y, Hamazaki Y, et al. Regional calcified plaque score evaluated by multidetector computed tomography for predicting the addition of rotational atherectomy during percutaneous coronary intervention[J]. J Cardiovasc Comput Tomogr, 2016, 10(3):221-228.
[31]
陈华, 赵施竹. 急性胸痛患者总冠状动脉钙化和局部钙化的差异与急性冠脉综合征及主要病变之间的关系[J]. 实用医学影像杂志, 2022, 23(1):38-43.
[32]
中华医学会放射学分会心胸学组, «中华放射学杂志»心脏冠状动脉多排CT临床应用指南写作专家组. 心脏冠状动脉CT血管成像技术规范化应用中国指南[J]. 中华放射学杂志, 2017, 51(10):732-743.
[1] 张源祥, 邱银汝, 梁志尧, 谢微, 刘福秀, 陈铭, 苏艳芳, 王茹, 傅宴. 三磷酸腺苷和多巴酚丁胺负荷超声造影在冠心病诊断中的对比研究[J]. 中华医学超声杂志(电子版), 2020, 17(04): 335-340.
[2] 张源祥, 邱银汝, 梁志尧, 谢微, 刘福秀, 陈铭, 苏艳芳, 王茹, 傅宴. 多巴酚丁胺负荷超声造影诊断冠心病的初步研究[J]. 中华医学超声杂志(电子版), 2020, 17(04): 327-334.
[3] 吴聪聪, 李开军, 徐剑, 林莉. 绝经后女性冠状动脉钙化患者的相关危险因素分析[J]. 中华危重症医学杂志(电子版), 2022, 15(02): 118-121.
[4] 周忠琴, 文凌仪, 郭应坤. 川崎病患儿冠状动脉微循环功能评估及其临床应用研究现状[J]. 中华妇幼临床医学杂志(电子版), 2020, 16(06): 621-626.
[5] 向文静, 何建华, 董贝贝, 陈晓涛. 慢性牙周炎伴冠心病患者Th17/Treg细胞平衡的临床意义[J]. 中华口腔医学研究杂志(电子版), 2020, 14(05): 302-307.
[6] 金艳盛, 董改琴, 李晓忠. 巨噬细胞在慢性肾脏病患者血管钙化中的作用与机制研究进展[J]. 中华肾病研究电子杂志, 2023, 12(04): 234-237.
[7] 罗珊, 欧三桃. 激活素A在慢性肾脏病血管钙化中的作用机制研究进展[J]. 中华肾病研究电子杂志, 2022, 11(06): 353-356.
[8] 熊琳, 欧三桃. 慢性肾脏病的"骨-血管轴"的交互因子研究进展[J]. 中华肾病研究电子杂志, 2022, 11(06): 342-346.
[9] 夏庆玲, 欧三桃. 成纤维细胞生长因子21与血管钙化关系研究进展[J]. 中华肾病研究电子杂志, 2022, 11(04): 231-234.
[10] 韦有欣, 邬元平, 陈白生, 邢昌赢. 血清dp-ucMGP水平与维持性血液透析患者血管钙化的相关性研究[J]. 中华肾病研究电子杂志, 2021, 10(06): 311-316.
[11] 于涵, 王保兴. 慢性肾脏病血管钙化的分子机制研究进展[J]. 中华肾病研究电子杂志, 2021, 10(04): 232-235.
[12] 熊鑫, 邓勇志. 基于血管内超声的机器学习在冠状动脉病变中的研究进展[J]. 中华诊断学电子杂志, 2023, 11(03): 153-157.
[13] 蔺曜, 黄晓玲, 何昭霞, 牟博勇, 牟燕. 血浆同型半胱氨酸水平对女性高血压患者冠状动脉病变的预测价值[J]. 中华诊断学电子杂志, 2022, 10(01): 48-52.
[14] 郑理, 徐勇, 刘妍. 老年慢性肾脏病3~4期患者单核细胞和高密度脂蛋白比值与腹主动脉钙化的关系[J]. 中华老年病研究电子杂志, 2022, 09(03): 6-11.
[15] 孙玉娟, 徐纯鑫, 袁静, 鄢华. 女性非阻塞性急性冠状动脉综合征的研究进展[J]. 中华脑血管病杂志(电子版), 2021, 15(01): 16-21.
阅读次数
全文


摘要